| Monitoring Chronic Myeloid Leukemia |
|
|
Many sophisticated tests are now available to help doctors track people's response to chronic myeloid leukemia (CML) treatment. The following programs will help you gain a better understanding of how doctors measure treatment progress.
|
|
Monitoring and Adherence in CML |
| Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance. |
Watch Video >> Read Transcript >> |
|
| Monitoring Therapy in Chronic Myeloid Leukemia |
| The goal of CML treatment is to restore blood cells to normal and to eliminate all cells that contain the Philadelphia chromosome. Learn about the tests doctors use to gather this information and monitor the health of people with CML. |
| Watch Video >>Read Transcript >> |
|
| Monitoring Treatment in CML |
| During treatment for CML, your doctor will rely on various tests to help him or her determine how well you are responding. These include tests that are used to initially diagnose the disease. |
|
Read Article >> |
|
| Measure for Measure: Tracking Treatment Progress in CML |
| When someone has cancer, doctors carefully monitor how well he or she responds to treatment. In chronic myeloid leukemia, the results of various blood and DNA tests act as a barometer for treatment effectiveness, helping doctors and patients determine the next best steps in treatment. |
|
Read Article >> |
|
| Overcoming Treatment Resistant CML |
| If one promising drug can fails to help against chronic myeloid leukemia, what can be done? Listen to experts explain your options for hard to treat cancers. |
| Watch Video >>Read Transcript >> |
|
| Introduction to CML |
| Chronic myeloid leukemia is a form of cancer that typically occurs in adults over the age of 40. Here's what you need to know about this disease. |
| Watch Video >>Read Transcript >> |
|
